What do clinical trial results really tell us
the study physician attributed the death to pre-existing coronary artery disease unrelated to the drug, but the FDA's Pharmacy Compounding Advisory Committee cited this "unresolved cardiac signal" in December 2024 as a reason to keep the compound off the approved compounding list
Other research suggests that weight loss alone may not fully explain the shedding
(His IMDB profile, which lists two daytime television appearances, has him at 6'5".) When I attempted to put my questions to Robertson, he told mewith the sort of strained, passive-aggressive politeness that typified so many of my customer service interactions with his companyto please leave. In 2024, the US Department of Justice and the Federal Trade Commission announced a suit against Robertson for, in part, the use of deceptive, burdensome and convoluted cancellation practices. Several of Robertsons companies, including Cerebral as well as Zealthy, were named in the suit
Because the study was observational, differences in diabetes severity, cardiovascular disease, obesity, and other patient characteristics may have influenced the results despite statistical adjustments
/assets/images/provider/photos/2840805.png)
:upscale()/2024/09/19/768/n/49351082/tmp_kfDUx8_8844982382f654b3_SHOT-11-GLP-72-0.JPEG)
